About Us

Thrixen was founded by international scientists from multidisciplinary areas from Singapore and USA in 2021 as a spin off from SMART (Singapore MIT Alliance for Research and Technology). Through many years of research, we have created a set of proprietary technologies that revolutionize biomarker detection and rapid assay generation, unlocking a range of new possibilities for diagnostics.

Our Technology

At Thrixen we are developing a diagnostic technology platform to make diagnostics available when and where they matter most. Our proprietary engineered protein binders combined with a unique assay format allow us to bring essential diagnostics closer to the patients, affordably and at scale.